NVIV

InVivo Therapeutics News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
InVivo Therapeutics Holdings Corporation NVIV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0238 -3.72% 0.616199 10:09:58
Open Price Low Price High Price Close Price Previous Close
0.62 0.6123 0.63 0.64
more quote information »

Recent News

Date Time Source Heading
12/03/202012:59IHNWFeaturedVinco Ventures, Inc. announces deal with OPTEC International, Inc. and OPTEC Brand Ambassador Dr. Drew Pinsky
12/04/20208:31IHNWFeaturedManganese X Subsidiary and JV Partner Form PureBiotic Air Inc. and  Expand Testing of HVAC Air Purification Delivery System
11/06/202016:31EDGARSecurities Registration: Employee Benefit Plan (s-8)
11/02/202016:11EDGARStatement of Ownership (sc 13g)
10/26/202016:15BWInVivo Therapeutics Announces Closing of $15.0 Million..
10/26/202006:03EDGARCurrent Report Filing (8-k)
10/26/202006:02EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
10/23/202016:39EDGARStatement of Ownership (sc 13g)
10/22/202009:15BWInVivo Therapeutics Announces Pricing of $15.0 Million..
10/07/202006:01EDGARSecurities Registration Statement (s-1)
9/11/202008:30BWInVivo Therapeutics Announces Presentation at the Upcoming..
8/11/202016:15EDGARQuarterly Report (10-q)
8/05/202016:34EDGARCurrent Report Filing (8-k)
6/23/202018:37EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202006:04EDGARProxy Statement (definitive) (def 14a)
6/09/202016:31EDGARProxy Statement - Notice of Shareholders Meeting..
6/05/202016:06EDGARCurrent Report Filing (8-k)
6/05/202006:01EDGARNotice of Effectiveness (effect)
6/04/202016:35EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/22/202017:26EDGARSecurities Registration Statement (s-1)
5/13/202016:07EDGARQuarterly Report (10-q)
4/28/202016:15EDGARSmall Company Offering and Sale of Securities Without..
4/24/202017:05EDGARStatement of Ownership (sc 13g)
4/24/202016:15EDGARStatement of Ownership (sc 13g)
4/24/202011:19EDGARStatement of Ownership (sc 13g)
4/17/202012:19BWInVivo Therapeutics Announces Closing of $3.0 Million..
4/17/202006:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/16/202017:20EDGARCurrent Report Filing (8-k)
4/16/202011:30EDGARStatement of Ownership (sc 13g)
4/15/202019:30BWInVivo Therapeutics Announces $3.0 Million Registered Direct..
3/16/202016:45EDGARStatement of Ownership (sc 13g)
3/12/202019:02EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202019:02EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202019:02EDGARStatement of Changes in Beneficial Ownership (4)
3/11/202016:27BWInVivo Therapeutics Announces Closing of $7.0 Million Public..
3/11/202016:06EDGARCurrent Report Filing (8-k)
3/09/202017:10EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
3/09/202006:01EDGARNotice of Effectiveness (effect)
3/06/202009:15BWInVivo Therapeutics Announces Pricing of $7.0 Million Public..
3/05/202006:08EDGARSecurities Registration Statement (s-1/a)
3/02/202017:31EDGARSecurities Registration Statement (s-1/a)
3/02/202016:06EDGARCurrent Report Filing (8-k)
2/24/202016:32EDGARAmended Current Report Filing (8-k/a)
2/21/202017:00EDGARSecurities Registration Statement (s-1)
2/20/202016:54EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/20/202016:07EDGARAnnual Report (10-k)
2/11/202017:07EDGARCurrent Report Filing (8-k)
2/03/202016:36EDGARCurrent Report Filing (8-k)
2/03/202016:30BWInVivo Therapeutics Announces Reverse Stock Split
1/24/202016:32EDGARCurrent Report Filing (8-k)
1/16/202016:31EDGARCurrent Report Filing (8-k)
12/23/201917:24EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
NVIV
InVivo The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.